U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H28N2O.ClH
Molecular Weight 384.942
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of IFERANSERIN HYDROCHLORIDE

SMILES

Cl.CN1CCCC[C@H]1CCC2=C(NC(=O)\C=C\C3=CC=CC=C3)C=CC=C2

InChI

InChIKey=MUJUAUCDSMLOTP-QWCHHRGUSA-N
InChI=1S/C23H28N2O.ClH/c1-25-18-8-7-12-21(25)16-15-20-11-5-6-13-22(20)24-23(26)17-14-19-9-3-2-4-10-19;/h2-6,9-11,13-14,17,21H,7-8,12,15-16,18H2,1H3,(H,24,26);1H/b17-14+;/t21-;/m0./s1

HIDE SMILES / InChI

Description

Originator

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trial.
2012-02

Sample Use Guides

In Vivo Use Guide
Intra-Anal Application of Iferanserin (10 mg) as a 0.5% Ointment
Route of Administration: Other
Name Type Language
IFERANSERIN HYDROCHLORIDE
Common Name English
2-PROPENAMIDE, N-(2-(2-((2S)-1-METHYL-2-PIPERIDINYL)ETHYL)PHENYL)-3-PHENYL-, MONOHYDROCHLORIDE
Preferred Name English
2-PROPENAMIDE, N-(2-(2-((2S)-1-METHYL-2-PIPERIDINYL)ETHYL)PHENYL)-3-PHENYL-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
FDA UNII
HVL2N1I37F
Created by admin on Mon Mar 31 18:07:25 GMT 2025 , Edited by admin on Mon Mar 31 18:07:25 GMT 2025
PRIMARY
CAS
210350-29-1
Created by admin on Mon Mar 31 18:07:25 GMT 2025 , Edited by admin on Mon Mar 31 18:07:25 GMT 2025
PRIMARY
PUBCHEM
56835812
Created by admin on Mon Mar 31 18:07:25 GMT 2025 , Edited by admin on Mon Mar 31 18:07:25 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of IFERANSERIN
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966